In vivo production of leukotriene B4 and leukotriene C4 in rabbit colitis. Relationship to inflammation.
Leukotriene B4, a proinflammatory compound, recently has been identified as the major metabolite of arachidonic acid in tissue incubations of human and animal colitis. To determine the relationship of inflammation to the in vivo production of leukotrienes, rabbit colitis was induced by formalin enema followed by intravenous infusion of immune complexes, and serial samples were collected by rectal dialysis. Leukotrienes B4 and C4 were measured by radioimmunoassay after high-pressure liquid chromatography. Prostaglandin E2 was assayed after Sephadex chromatography. Leukotrienes were not detected in control animals. Eicosanoid production progressively increased during development of inflammation and correlated with severity of inflammatory cell infiltration (p less than 0.01). Methylprednisolone decreased prostaglandin E2 but did not significantly reduce leukotrienes or inflammation. These data demonstrate that in vivo production of leukotrienes B4 and C4 correlates with indices of inflammation, consistent with the concept that these eicosanoids contribute to the inflammation of colitis.
D000818:Animals; D002851:Chromatography, High Pressure Liquid; D003092:Colitis / Q000188:drug therapy / Q000378:metabolism*; D015232:Dinoprostone; D007413:Intestinal Mucosa / Q000378:metabolism; D007975:Leukotriene B4 / Q000096:biosynthesis*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D011458:Prostaglandins E / Q000096:biosynthesis; D011817:Rabbits; D011863:Radioimmunoassay; D013189:SRS-A / Q000096:biosynthesis*
D011458:Prostaglandins E; D013189:SRS-A; D007975:Leukotriene B4; D015232:Dinoprostone; D008775:Methylprednisolone